Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options

This publication has 47 references indexed in Scilit:

• The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial
  American Heart Journal, 2005
• Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)
  The American Journal of Cardiology, 2005
• Description of modern practices of percutaneous coronary intervention and identification of risk factors for adverse outcome in the French nationwide OPEN registry
  Heart, 2005
• Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized, controlled trials
  American Heart Journal, 2004
• Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study)
  The American Journal of Cardiology, 2004
• Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale
  American Heart Journal, 2004
• Bivalirudin in PCI: An Overview of the REPLACE-2 Trial
  Seminars in Thrombosis and Hemostasis, 2004
• P2Y₁₂, A New Platelet ADP Receptor, Target of Clopidogrel
  Seminars in Vascular Medicine, 2003
• Patterns of use of heparins in ACS
  Thrombosis and Haemostasis, 2003
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995